Abstract
Pathway-based analysis approach has exploded in use during the last several years. It is successful in recognizing additional biological insight of disease and finding groupings of risk genes that represent disease developing processes. Therefore, shared pathways, with pleiotropic effects, are important for understanding similar pathogenesis and indicating the common genetic origin of certain diseases. Here, we present a pathway analysis to reveal the potential disease associations between RA and three potential RA-related autoimmune diseases: psoriasis, diabetes mellitus, type 1 (T1D) and systemic lupus erythematosus (SLE). First, a comprehensive knowledge mining of public databases is performed to discover risk genes associated with RA, T1D, SLE and psoriasis; then by enrichment test of these genes, disease-related risk pathways are detected to recognize the pathways common for RA and three other diseases. Finally, the underlying disease associations are evaluated with the association rules mining method. In total, we identify multiple RA risk pathways with significant pleiotropic effects, the most unsurprising of which are the immunology related pathways. Meanwhile for the first time we highlight the involvement of the viral myocarditis pathway related to cardiovascular disease (CVD) in autoimmune diseases such as RA, psoriasis, T1D and SLE. Further Association rule mining results validate the strong association between RA and T1D and RA and SLE. It is clear that pleiotropy is a common property of pathways associated with disease traits. We provide novel pathway associations among RA and three autoimmune diseases. These results ascertain that there are shared genetic risk profiles that predispose individuals to autoimmune diseases.
Similar content being viewed by others
References
Li Y., Begovich A.B. 2009. Unraveling the genetics of complex diseases: Susceptibility genes for rheumatoid arthritis and psoriasis. Semin. Immunol. 21, 318–327.
van Driel M.A., Bruggeman J., Vriend G., Brunner H.G., Leunissen J.A. 2006. A text-mining analysis of the human phenome. Eur. J. Hum. Genet. 14, 535–542.
Fehringer G., Liu G., Briollais L., Brennan P., Amos C.I., Spitz M.R., Bickeboller H., Wichmann H.E., Risch A., Hung R.J. 2012. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS ONE. 7, e31836.
Jin L., Zuo X.Y., Su W.Y., Zhao X.L., Yuan M.Q., Han L.Z., Zhao X., Chen Y.D., Rao S.Q. 2014. Pathway- based analysis tools for complex diseases: A review. Genom. Proteom. Bioinform. 12, 210–220.
Ramanan V.K., Shen L., Moore J.H., Saykin A.J. 2012. Pathway analysis of genomic data: Concepts, methods, and prospects for future development. Trends Genet. 28, 323–332.
Rappaport N., Nativ N., Stelzer G., Twik M., Guan- Golan Y., Stein T.I., Bahir I., Belinky F., Morrey C.P., Safran M., Lancet D. 2013). MalaCards: An integrated compendium for diseases and their annotation. Database (Oxford). 2013, bat018.
Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabasi A.L. 2007. The human disease network. Proc. Natl. Acad. Sci. U. S. A. 104, 8685–8690.
Dabrowska-Zamojcin E., Herczynska M.M., Pawlik A. 2013. Association between AIF-1 gene polymorphisms and response to rheumatoid arthritis treatment with sulphasalazine. Ann. Acad. Med. Stetin. 59, 39–42.
Agrawal R., I. T., Swami A. 1993. Mining association rules between sets of items in large databases. SIGMOD. 22, 207–216.
Li Y., Agarwal P. 2009. A pathway-based view of human diseases and disease relationships. PLoS ONE. 4, e4346.
Elliott J.R., Manzi S. 2009. Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 23, 481–494.
Kanehisa M., Goto S. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30.
Liu G., Yao L., Liu J., Jiang Y., Ma G., Genetic, Environmental Risk for Alzheimer’s disease (GERAD1) Consortium, Chen Z., Zhao B., Li K. 2014. Cardiovascular disease contributes to Alzheimer’s disease: Evidence from large-scale genome-wide association studies. Neurobiol. Aging. 35, 786–792.
Wang B., Sun S., Liu Z. 2014. Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile. Mol. Biol. Rep. 41, 4361–4367.
Wang Y., Xu G., Chen W., Pan Q., Huang K., Pan J., Zhang W., Chen J. 2015. Detection of long-chain nonencoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification. Mol. Med. Rep. 11, 1925–1932.
Pham T., Gossec L., Constantin A., Pavy S., Bruckert E., Cantagrel A., Combe B., Flipo R. M., Goupille P., Le Loet X., Mariette X., Puechal X., Schaeverbeke T., Sibilia J., Tebib J., et al. 2006. Cardiovascular risk and rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine. 73, 379–387.
Kaplan M.J. 2006. Cardiovascular disease in rheumatoid arthritis. Curr. Opin. Rheumatol. 18, 289–297.
Magder L.S., Petri M. 2012. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am. J. Epidemiol. 176, 708–719.
Imazu M., Sumii K., Yamamoto H., Toyofuku M., Tadehara F., Okubo M., Yamakido M., Kohno N., Onaka A.T., Hawaii–Angeles–Hiroshima Study. 2002. Influence of type 2 diabetes mellitus on cardiovascular disease mortality: Findings from the Hawaii–Los Angeles–Hiroshima study. Diabetes Res. Clin. Pract. 57, 61–69.
Erkens J.A., Herings R.M., Stolk R.P., Spoelstra J.A., Grobbee D.E., Leufkens H.G. 2002. Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus. J. Clin. Epidemiol. 55, 345–349.
Gordon-Dseagu V.L., Shelton N., Mindell J. 2014. Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: Evidence from the Health Survey for England and Scottish Health Survey cohorts. J. Diabet. Complicat. 28, 791–797.
Saboo B. 2015. Key elements of successful intensive therapy in patients with type 1 diabetes. Indian J. Endocrinol. Metab. 19, S44–S46.
Ortega E., Amor A.J., Rojo-Martinez G., Castell C., Gimenez M., Conget I. 2015. Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain. Med. Clin (Barc). 145 (6), 233–238.
Khraishi M., Aslanov R., Rampakakis E., Pollock C., Sampalis J.S. 2014. Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin. Rheumatol. 33, 1495–1500.
Torkamani A., Topol E.J., Schork N.J. 2008. Pathway analysis of seven common diseases assessed by genomewide association. Genomics. 92, 265–272.
Zenewicz L.A., Abraham C., Flavell R.A., Cho J.H. 2010. Unraveling the genetics of autoimmunity. Cell. 140, 791–797.
Chelala C., Duchatelet S., Joffret M.L., Bergholdt R., Dubois-Laforgue D., Ghandil P., Pociot F., Caillat-Zucman S., Timsit J., Julier C. 2007. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes. 56, 522–526.
Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., Wolfe F., Kastner D.L., Alfredsson L., Altshuler D., Gregersen P.K., Klareskog L., Rioux J.D. 2005. Replication of putative candidategene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum. Genet. 77, 1044–1060.
Zucker-Franklin D., Hooper W.C., Evatt B.L. 1992. Human lymphotropic retroviruses associated with mycosis fungoides: Evidence that human T-cell lymphotropic virus type II(HTLV-II) as well as HTLV-I may play a role in the disease. Blood. 80, 1537–1545.
Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., Gianniny L., Korman B.D., Padyukov L., Kurreeman F.A., Chang M., Catanese J.J., Ding B., Wong S., van der Helm- van Mil A.H., et al. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40, 1216–1223.
Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., Moser K.L., Begovich A.B., Carlton V.E., Li W., Lee A.T., Ortmann W., Behrens T.W., Gregersen P.K. 2005. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76, 561–571.
Liao K.P., Gunnarsson M., Kä llberg H., Ding B., Plenge R.M., Padyukov L., Karlson E.W., Klareskog L., Askling J., Alfredsson L. 2009. A specific association exists between type 1 diabetes and anti-CCP positive rheumatoid arthritis. Arthritis Rheum. 60, 653–660.
Torfs C.P., King M.C., Huey B., Malmgren J., Grumet F.C. 1986. Genetic interrelationship between insulin- dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am. J. Hum. Genet. 38, 170–187.
Lin J.P., Cash J.M., Doyle S.Z., Peden S., Kanik K., Amos C.I., Bale S.J., Wilder R.L. 1998. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum. Genet. 103, 475–782.
Schaub M.A., Kaplow I.M., Sirota M., Do C.B., Butte A.J., Batzoglou S. 2009. A classifier-based approach to identify genetic similarities between diseases. Bioinformatics. 25, i21–i29.
The Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature. 447, 661–678.
Eleftherohorinou H., Wright V., Hoggart C., Hartikainen A.L., Jarvelin M.R., Balding D., Coin L., Levin M. 2009. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS ONE. 4, e8068.
Jessica A., Stanich J.D.C., Judith Whittum-Hudson Alan P. Hudson. 2009. Rheumatoid arthritis: Disease or syndrome? Open Access Rheumatol. Res. Rev. 1, 179–192.
The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature. 437, 1299–1320.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Molekulyarnaya Biologiya, 2016, Vol. 50, No. 3, pp. 530–539.
The article is published in the original.
Rights and permissions
About this article
Cite this article
Zheng, WY., Zheng, WX. & Hua, L. Detecting shared pathways linked to rheumatoid arthritis with other autoimmune diseases in a in silico analysis. Mol Biol 50, 462–469 (2016). https://doi.org/10.1134/S0026893316030146
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893316030146